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Abstract
Purpose The aim was to analyze whether or not weight gain influences the treatment outcome of patients with obstructive sleep
apnea (OSA) treated with mandibular advancement devices (MAD).
Methods As a part of a follow-up study amongOSA patients treated withMAD in primary oral health care, a group of 28 patients
reporting worsening of daytime or nighttime symptoms of OSA was given closer examination. Altogether, 21 subjects had a
complete set of recordings and were enrolled into the study.
Results Only three subjects had lost weight during the study period. The mean weight gain of 3.6 kg ± 7.1 kgwas significant (p =
0.035). According to linear regression, weight gain was independently significantly associated with lower mean peripheral
oxygen saturation 92.4 (SD 1.8 (% per hour) (p = 0.019)) and lowest oxygen saturation 80.1 (SD 7.2 (%) (p = 0.024)) scores.
Conclusions Weight gain is detrimentally associated with MAD treatment in patients with OSA. These findings suggest that
regular follow-up by an experienced dentist is advisable to assess for possible worsening of OSA. Patient support to encourage
weight control may be an important adjunct to MAD treatment for OSA.
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Introduction
Obstructive sleep apnea (OSA) is a common breathing disor-
der characterized by upper airway collapse during sleep.
When obstructions occur repeatedly, they may result in oxy-
gen desaturation and arousals from sleep [1]. OSA is a grow-
ing global health problem [1, 2]. Its major risk factors are
overweight or obesity, gender, age, and craniofacial anatomy.
Its major symptoms are snoring with witnessed apneas and
daytime tiredness [1]. Untreated OSAmay lead to other severe
conditions as myocardial infarction, congestive heart failure,
stroke, and diabetes mellitus [1].
The gold standard for treating OSA is the continuous pos-
itive airway pressure device (CPAP) [3, 4]. However, mandib-
ular advancement devices (MAD) have also been shown to be
effective, especially in the treatment of mild to moderate OSA
[5, 6]. In fact, some studies have reported comparable out-
comes with MAD and CPAP [7, 8]. Also, follow-up studies
have shown good compliance with MAD and that the treat-
ment can improve patients’ quality of life and sleep, reduce
loud snoring, and decrease daytime tiredness [9, 10]. In a
recent study by Gjerde et al. [11], MADs also showed prom-
ising outcomes in moderate and severe OSA patients who did
not adapt to CPAP treatment.
Two out of three patients with OSA are reportedly over-
weight [12]. According to the World Health Organization
(WHO), worldwide obesity has more than doubled since
* Tiina-Riitta Vuorjoki-Ranta
tiina-riitta.vuorjoki-ranta@hel.fi
1 City of Helsinki, Department of Social Services and Health Care,
POB 6420, 00099 Helsinki, Finland
2 Department of Oral Kinesiology, Academic Centre for Dentistry
Amsterdam (ACTA), Research Institute MOVE, University of
Amsterdam and VU University Amsterdam,
Amsterdam, The Netherlands
3 Oivauni Sleep Clinic, Kuopio, Finland
4 Institute of Public Health and Clinical Nutrition, Department of
Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
5 Oral and Maxillofacial Diseases, University of Helsinki,
Helsinki, Finland
6 City of Helsinki, Department of Social Services and Health Care,
Unit for Specialized Oral Care in the Metropolitan Area and
Kirkkonummi, Helsinki, Finland
7 Institute of Dentistry, University of Eastern Finland, Kuopio, Finland
Sleep and Breathing (2019) 23:531–534
https://doi.org/10.1007/s11325-018-1728-1
1980. In 2014, 39% of adults over 18 years were overweight
(body mass index, BMI, equal to 25 or more) and 13% were
obese (BMI equal to 30 or more) [13]. The growing problem
of weight gain augments the number of patients with OSA
worldwide, increasing the economic burden across societies.
Weight has a significant role not only in the development of
OSA, but also in the progression of the disease. A study by
Berger et al. [14] showed that the increase in apnea-hypopnea
index (AHI) was mainly dependent on an increase in BMI.
Peppard et al. [15] found in their longitudinal study that a 10%
weight gain predicts a 32% increase in AHI. Tuomilehto et al.
[16] and Kajaste et al. [17] underscored the importance of
weight reduction in the treatment of mild OSA. A recent study
by Kulkas et al. [18], in which they used a novel-adjusted AHI
parameter (incorporating individual event severity, i.e., taking
into account the morphology, duration, and depth of obstruc-
tion events), demonstrated that weight loss, in particular, af-
fects more positively the individual respiratory events in non-
supine than in supine position.
Oxygen saturation during sleep is important for assessing
the severity of OSA. A study by Gries et al. [19] showed that
the mean oxygen saturation level was significantly lower in
OSA patients than in healthy subjects (93.5 ± 3.8 vs. 96.5 ±
1.5, p < 0.0005). A corresponding difference was also found
in the lowest oxygen saturation level, respectively (65.9 ±
22.6 vs. 90.4 ± 3.1, p < 0.0005).
Good compliance was found in a long-term follow-up ran-
domized controlled trial performed on patients with OSA
treated with oral appliances [9], as well as in earlier studies
[5]. However, in another study among general dental practi-
tioners and specialist dentists working in community dental
care, we found differences in their knowledge and attitudes of
how to treat these patients [20]. Nevertheless, among those
patients who continued visiting a dentist in the community
dental care clinic, some complained of recurrent symptoms
of OSA, despite regular use of the MAD. These patients were
referred for more detailed examinations. In the present retro-
spective study using patient records, we aimed to evaluate
whether or not changes in weight played a role in the worsen-
ing of OSA.
Material and methods
The clinical records of 28 patients with OSA (age range 39–
75 years, 14 men) were retrospectively examined. Twenty-one
patients had a complete set of recordings and were eligible for
the study. All patients had been treated with a similar Herbst-
type MAD, which was fabricated free of charge to them in
community dental care in Helsinki, Finland. All MADs were
fabricated at the same dental laboratory and adjusted by a
specialist dentist. The patients included in the present study
had complained of worsening recurrent symptoms despite the
ongoing treatment with MAD and were seeking care on their
own initiative. Both the diagnostic study prior to treatment
and the control studies were performed at home using an am-
bulatory, level 3 polysomnographic (PSG) device (Nox T3,
Resmed®). All subjects gave a written consent.
The following data were recorded during record review for
the present study:
Descriptive data: gender, age, average follow-up time in
years, weight at baseline and at follow-up PSG recordings,
former treatment of OSA beforeMAD treatment, and ongoing
medications.
Data from PSG recordings: apnea-hypopnea index (AHI)
in respiratory events per hour, snoring, and mean and lowest
peripheral oxygen saturation percentages.
Statistical methods
Paired sample t test was used to compare the mean outcomes
between the two occasions. Linear regression models were
fitted to analyze the associations of weight change and the
variation of AHI, mean oxygen saturation score (mean %
per hour), and lowest oxygen saturation score (%) during the
follow-up sleep study. Independent variables entered in the
models were age (years), gender (male = 0, female = 1), and
weight change (kilograms). SPSS® statistical software (ver-
sion 22) was used for the analyses.
Results
Altogether, 21 patients were included in the present study, 12
men (mean age 58.5; SD 9.5) and 9 women (mean age 64.0;
SD 9.2, p = 0.20). Themean follow-up timewas 5.5 years (SD
1.8).
Prior toMAD treatment, CPAPwas unsuccessfully used by
three patients. After the diagnostic PSG, treatment with CPAP
was initiated for 17 patients. Regular medication for elevated
blood pressure was used by 67% of patients, regular use of
statins by 38%, and anticoagulants and thyroxine by 24%.
One patient had no regular medication.
Table 1 Mean values of the studied items prior to treatment and at visit
with MAD in use. Paired sample t test
Prior to treatment With MAD
n = 21 Mean SD Mean SD p value
Weight (kg) 84.6 11.3 88.2 13.7 0.035
AHI 22.1 16.6 19.3 13.9 0.44
Oxygen saturation (%/hour) 93.5 1.8 92.4 1.8 0.001
Lowest oxygen saturation (%) 84.4 7.7 80.1 7.3 0.23
AHI apnea/hypopnea index, SD standard deviation
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Only three subjects had lost weight during the study period.
The mean weight gain was significant (p = 0.035) (Table 1).
Also, the mean peripheral percentage oxygen saturation was
significantly lower at follow-up with MAD in use than at
baseline before treatment (p = 0.001) (Table 1).
According to linear regression, weight gain was independent-
ly significantly associated with the lower mean peripheral oxy-
gen saturation (% per hour) (p = 0.019) and lowest oxygen satu-
ration scores (p = 0.024) (Table 2). The age- and gender-adjusted
regression models explained 39% of the variation of mean oxy-
gen and 36% of the lowest oxygen saturations (Table 2).
Discussion
The main finding of our study is that in patients with OSA,
weight gain may negatively influence the effectivity of MAD
treatment. Additionally, continuing follow-up care may be
critically important to assure patients of effective therapy with
MAD.
The patient medical history of sleep-related symptoms
along with the number of respiratory events per hour (apnea-
hypopnea index or AHI) has long been the standard way to
measure severity of sleep apnea. A single apnea or hypopnea
is defined as an event of 10 s or longer. The convention used to
classify OSA severity categorizes OSA as mild for 5–14 re-
spiratory events per hour, moderate for 15–30 events per hour,
and severe for 30 or more events per hour [4]. However, recent
studies have introduced the importance of more accurate di-
agnostics to capture a more complete picture of OSA. It has
been suggested that the degree of severity of OSA should not
depend only on the number of respiratory events, but should
also consider the duration of events and the effect on oxygen
desaturations [21]. Our findings regarding oxygen saturation
do lend support to the idea of seeking a more complete de-
scription of OSA severity.
Previous studies have shown that weight reduction posi-
tively influences sleep apnea patients [15, 16]. In 2000,
Peppard et al. found that weight change was positively related
to change in AHI [15]. They defined even more specifically
that a one percentage change in weight was associated with
approximately 3% change in AHI. Also, Tuomikoski et al.
studied mild OSA patients and found an average of 10.6%
weight loss also improved the mean oxygen saturation [16].
It is noteworthy that weight gain occurred in the majority of
our patients. Furthermore, our results indicate that even a rel-
atively slight increase in weight may be detrimental to MAD
treatment outcome. Due to weight gain, 17 of our 21 patients
required the initiation of CPAP treatment.
A limitation of the present study is the relatively small
sample size. All conclusions must therefore be drawn cau-
tiously. Furthermore the subjects in our study were a conve-
nience sample of patients seeking care for their worsened
symptoms of OSA, despite the ongoing MAD treatment.
Only those who had a complete set of recordings were eligible
for the study. These circumstances imply that our study pop-
ulation was highly selected decreasing our ability to general-
ize our findings to other populations. Another limitation of the
present study is there was no control group enrolled. However,
our retrospective clinical setting may contribute pragmatic
data from real-life conditions [22].
Our results suggest the need for regular monitoring of pa-
tients with OSAwho receive MAD therapy. Our findings fur-
ther suggest that for patients with OSA, a more intensive focus
on weight control is necessary.
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